These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5125476)

  • 41. Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates.
    Vogel WH; Mahoney K; Hare TA
    Arch Int Pharmacodyn Ther; 1972; 198(1):85-93. PubMed ID: 4538242
    [No Abstract]   [Full Text] [Related]  

  • 42. Genetics of audiogenic seizures: II. Effects of pharmacological manipulation of brain serotonin, norepinephrine and gamma-aminobutyric acid.
    Schlesinger K; Boggan W; Freedman DX
    Life Sci; 1968 Apr; 7(7):437-47. PubMed ID: 4385105
    [No Abstract]   [Full Text] [Related]  

  • 43. Behavioral reaction of rats pretreated with reserpine to LSD-25.
    Votava Z; Glisson SN; Himwich HE
    Int J Neuropharmacol; 1967 Nov; 6(6):543-7. PubMed ID: 5586670
    [No Abstract]   [Full Text] [Related]  

  • 44. Functional role of the nigro-neostriatal dopamine neurons.
    Andén NE; Dahlström A; Fuxe K; Larsson K
    Acta Pharmacol Toxicol (Copenh); 1966; 24(2):263-74. PubMed ID: 5297995
    [No Abstract]   [Full Text] [Related]  

  • 45. (S)-norepinephrine in the tissues of mice and rats given racemic erythro-3,4-dihydroxyphenylserine (DOPS).
    Porter CC; Torchiana ML; Stone CA
    Life Sci I; 1972 Aug; 11(16):787-95. PubMed ID: 4540250
    [No Abstract]   [Full Text] [Related]  

  • 46. Potentiation of the central nervous system effects of DOPA by decarboxylase inhibition: possible direct role of this neuroamino acid in brain mechanisms.
    Vazquez AJ; Sabelli HC
    Exp Neurol; 1975 Jan; 46(1):44-56. PubMed ID: 1109342
    [No Abstract]   [Full Text] [Related]  

  • 47. Enhancement of brain L-dopa concentration with -chymotrypsin.
    Seneca H; Henderson E
    J Am Geriatr Soc; 1973 Jun; 21(6):256-8. PubMed ID: 4710643
    [No Abstract]   [Full Text] [Related]  

  • 48. Behavioral and neurochemical effects of psychotomimetic drugs in neonate chicks.
    Wallach MB; Friedman E; Gershon S
    Eur J Pharmacol; 1972 Feb; 17(2):259-69. PubMed ID: 5026400
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 50. L-DOPA: effect on ethanol narcosis and brain biogenic amines in mice.
    Blum K; Calhoun W; Merritt J; Wallace JE
    Nature; 1973 Apr; 242(5397):407-9. PubMed ID: 4735636
    [No Abstract]   [Full Text] [Related]  

  • 51. The susceptibility to audiogenic stimuli of rats treated with methionine sulfoximine and various psychoactive agents.
    Wada JA; Ikeda H; McGeer EG
    Exp Neurol; 1967 Jul; 18(3):327-37. PubMed ID: 5298251
    [No Abstract]   [Full Text] [Related]  

  • 52. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of catecholamines on the central nervous system. (1). Role of dopamine in the brain in animal behavioral changes].
    Kameyama T; Kisara K
    Nihon Yakurigaku Zasshi; 1966 Sep; 62(5):317-26. PubMed ID: 5298294
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 55. Photic evoked cortical potentials: interaction of reserpine, monoamine oxidase inhibition, and DOPA.
    Sabelli HC; Giardina WJ; Bartizal F
    Biol Psychiatry; 1971; 3(3):273-80. PubMed ID: 5163812
    [No Abstract]   [Full Text] [Related]  

  • 56. 3,4-Dihydroxyphenylalanine (dopa), dopamine and norepinephrine storage in the rat heart after L-dopa--further evidence for norepinephrine release.
    Landsberg L; Bruno SJ
    Biochem Pharmacol; 1973 Feb; 22(3):417-25. PubMed ID: 4687136
    [No Abstract]   [Full Text] [Related]  

  • 57. Recovery of the amine uptake-storage mechanism in nerve granules after reserpine treatment: inhibition by axotomy.
    Andén NE; Lundborg P
    J Pharm Pharmacol; 1970 Mar; 22(3):233-5. PubMed ID: 4399497
    [No Abstract]   [Full Text] [Related]  

  • 58. Experimental study on the mechanism of depressogenic action of apomorphine and reserpine.
    Benesová O; Benes V
    Act Nerv Super (Praha); 1972 Nov; 14(4):269-72. PubMed ID: 4673427
    [No Abstract]   [Full Text] [Related]  

  • 59. Audiogenic seizures in mice: influence of agents affecting brain serotonin.
    Alexander GJ; Kopeloff LM
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):437-48. PubMed ID: 134436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spontaneous and L-DOPA induced circus movements in cats with brain stem lesions.
    Poirier LJ; Langelier P; Boucher R
    J Physiol (Paris); 1973; 66(6):735-54. PubMed ID: 4795092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.